# A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity

> **NCT03320941** · PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 126 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** LIK066
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03320941
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-07
- **Primary completion:** 2018-07-25
- **Final completion:** 2018-07-25
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2024-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03320941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03320941, "A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03320941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*